Skip to main content
Top
Published in: BMC Pediatrics 1/2018

Open Access 01-12-2018 | Research article

Challenges to and opportunities for the adoption and routine use of early warning indicators to monitor pediatric HIV drug resistance in Kenya

Authors: Nanlesta A. Pilgrim, Jerry Okal, James Matheka, Irene Mukui, Samuel Kalibala

Published in: BMC Pediatrics | Issue 1/2018

Login to get access

Abstract

Background

Pediatric non-adherence to antiretroviral therapy (ART), loss to follow-up, and HIV drug resistance (HIVDR) are challenges to achieving UNAIDS’ targets of 90% of those diagnosed HIV-positive receiving treatment, and 90% of those receiving treatment achieving viral suppression. In Kenya, the pediatric population represents 8% of total HIV infections and pediatric virological failure is estimated at 33%. The monitoring of early warning indicators (EWIs) for HIVDR can help to identify and correct gaps in ART program functioning to improve HIV care and treatment outcomes. However, EWIs have not been integrated into health systems. We assessed challenges to the use of EWIs and solutions to challenges identified by frontline health administrators.

Methods

We conducted key informant interviews with health administrators who were fully knowledgeable of the ART program at 23 pediatric ART sites in 18 counties across Kenya from May to June 2015. Thematic content analysis identified themes for three EWIs: on-time pill pick-up, retention in care, and virological suppression.

Results

Nine themes—six at the facility level and three at the patient level—emerged as major challenges to EWI monitoring. At the facility level, themes centered on system issues (e.g., slow return of viral load results), staff shortages and inadequate adherence counseling skills, lack of effective patient tracking and linkage systems, and lack of support for health personnel. At the patient level, themes focused on stigma, non-disclosure of HIV status to children who are age eligible, and little engagement of guardians in the children’s care.
Practical solutions identified included the use of lay health workers (e.g., peer educators, community health workers) to implement a variety of care and treatment tasks, whole facility approaches to adherence counseling, adolescent peer support groups, and working with children directly as soon as they are age eligible.

Discussion

The monitoring of EWIs has not been routine in health facilities in Kenya due to several challenges. However, facilities have implemented novel strategies to address some of these barriers. Future work is needed to assess whether scale-up of some of these approaches can aid in the effective use of EWIs and improving HIV care outcomes among the pediatric population.
Literature
1.
go back to reference UNAIDS. 90–90-90: an ambitious treatment target to help end the AIDS epidemic. Geneva: UNAIDS; 2014. UNAIDS. 90–90-90: an ambitious treatment target to help end the AIDS epidemic. Geneva: UNAIDS; 2014.
2.
go back to reference Davies M-A, Pinto J. Targeting 90–90–90–don't leave children and adolescents behind. J Int AIDS Soc 2015;18(7Suppl 6). Davies M-A, Pinto J. Targeting 90–90–90–don't leave children and adolescents behind. J Int AIDS Soc 2015;18(7Suppl 6).
3.
go back to reference UNAIDS. Country factsheets: Kenya 2016. Geneva: UNAIDS; 2017. UNAIDS. Country factsheets: Kenya 2016. Geneva: UNAIDS; 2017.
4.
go back to reference Kityo C, Sigaloff KCE, Boender TS, Kaudha E, Kayiwa J, Musiime V, et al. HIV drug resistance among children initiating first-line antiretroviral treatment in Uganda. AIDS Res Hum Retrovir. 2016;32(7):628–35.CrossRefPubMed Kityo C, Sigaloff KCE, Boender TS, Kaudha E, Kayiwa J, Musiime V, et al. HIV drug resistance among children initiating first-line antiretroviral treatment in Uganda. AIDS Res Hum Retrovir. 2016;32(7):628–35.CrossRefPubMed
5.
go back to reference Hamers RL, Sigaloff KC, Kityo C, Mugyenyi P, de Wit TFR. Emerging HIV-1 drug resistance after roll-out of antiretroviral therapy in sub-Saharan Africa. Curr Opin HIV AIDS. 2013;8(1):19–26.CrossRefPubMed Hamers RL, Sigaloff KC, Kityo C, Mugyenyi P, de Wit TFR. Emerging HIV-1 drug resistance after roll-out of antiretroviral therapy in sub-Saharan Africa. Curr Opin HIV AIDS. 2013;8(1):19–26.CrossRefPubMed
6.
go back to reference Wamalwa D, Lehman DA, Benki-Nugent S, Gasper M, Gichohi R, Maleche-Obimbo E, et al. Long-term virologic response and genotypic resistance mutations in HIV-1 infected Kenyan children on combination antiretroviral therapy. J Acquir Immune Defic Syndr. 2013;62(3):267.CrossRefPubMedPubMedCentral Wamalwa D, Lehman DA, Benki-Nugent S, Gasper M, Gichohi R, Maleche-Obimbo E, et al. Long-term virologic response and genotypic resistance mutations in HIV-1 infected Kenyan children on combination antiretroviral therapy. J Acquir Immune Defic Syndr. 2013;62(3):267.CrossRefPubMedPubMedCentral
7.
go back to reference Ngugi E, Nge’no B, Odhiambo F, Ojoo S, Masyuko S. Virologic response and genotypic resistance mutations in HIV infected children on combination antiretroviral therapy in Kenya. Poster presentation presented at 20th International AIDS Conference, Melbourne. vol. Abstract MOPE048. 2014; Ngugi E, Nge’no B, Odhiambo F, Ojoo S, Masyuko S. Virologic response and genotypic resistance mutations in HIV infected children on combination antiretroviral therapy in Kenya. Poster presentation presented at 20th International AIDS Conference, Melbourne. vol. Abstract MOPE048. 2014;
8.
go back to reference El-Khatib Z, Katzenstein D, Marrone G, Laher F, Mohapi L, Petzold M, et al. Adherence to drug-refill is a useful early warning indicator of virologic and immunologic failure among HIV patients on first-line ART in South Africa. PLoS One. 2011;6(3):e17518.CrossRefPubMedPubMedCentral El-Khatib Z, Katzenstein D, Marrone G, Laher F, Mohapi L, Petzold M, et al. Adherence to drug-refill is a useful early warning indicator of virologic and immunologic failure among HIV patients on first-line ART in South Africa. PLoS One. 2011;6(3):e17518.CrossRefPubMedPubMedCentral
10.
go back to reference Vreeman RC, Wiehe SE, Pearce EC, Nyandiko WM. A systematic review of pediatric adherence to antiretroviral therapy in low-and middle-income countries. Pediatr Infect Dis J. 2008;27(8):686–91.CrossRefPubMed Vreeman RC, Wiehe SE, Pearce EC, Nyandiko WM. A systematic review of pediatric adherence to antiretroviral therapy in low-and middle-income countries. Pediatr Infect Dis J. 2008;27(8):686–91.CrossRefPubMed
11.
go back to reference Abuogi LL, Smith C, McFarland EJ. Retention of HIV-infected children in the first 12 months of anti-retroviral therapy and predictors of attrition in resource limited settings: a systematic review. PLoS One. 2016;11(6):e0156506.CrossRefPubMedPubMedCentral Abuogi LL, Smith C, McFarland EJ. Retention of HIV-infected children in the first 12 months of anti-retroviral therapy and predictors of attrition in resource limited settings: a systematic review. PLoS One. 2016;11(6):e0156506.CrossRefPubMedPubMedCentral
12.
go back to reference World Health Organization. Global report on early warning indicators of HIV drug resistance: technical report. Geneva: World Health Organization; 2016. World Health Organization. Global report on early warning indicators of HIV drug resistance: technical report. Geneva: World Health Organization; 2016.
13.
go back to reference Ngugi E, Masyuko, S., Mukui, I., Katana, A., Waruru, A., Gichangi, A. Early warning indicators for HIV drug resistance in adult and pediatric antiretroviral therapy sites in Kenya: results of a national survey. Poster presentation presented at 7th conference on HIV pathogenesis, treatment, and prevention, Kuala Lumpur. Abstract MOPE184; 2013. Ngugi E, Masyuko, S., Mukui, I., Katana, A., Waruru, A., Gichangi, A. Early warning indicators for HIV drug resistance in adult and pediatric antiretroviral therapy sites in Kenya: results of a national survey. Poster presentation presented at 7th conference on HIV pathogenesis, treatment, and prevention, Kuala Lumpur. Abstract MOPE184; 2013.
14.
go back to reference Hsieh HF, Shannon SE. Three approaches to qualitative content analysis. Qual Health Res. 2005;15(9):1277–88.CrossRefPubMed Hsieh HF, Shannon SE. Three approaches to qualitative content analysis. Qual Health Res. 2005;15(9):1277–88.CrossRefPubMed
15.
go back to reference Brown NA, Smith KC, Thornton RL, Bowie JV, Surkan PJ, Thompson DA, et al. Gathering perspectives on extended family influence on African American children’s physical activity. J Health Dispar Res Pract. 2015;8(1):10.PubMedPubMedCentral Brown NA, Smith KC, Thornton RL, Bowie JV, Surkan PJ, Thompson DA, et al. Gathering perspectives on extended family influence on African American children’s physical activity. J Health Dispar Res Pract. 2015;8(1):10.PubMedPubMedCentral
16.
17.
go back to reference Pilgrim NA, Blum RW. Protective and risk factors associated with adolescent sexual and reproductive health in the English-speaking Caribbean: a literature review. J Adolesc Health. 2012;50(1):5–23.CrossRefPubMed Pilgrim NA, Blum RW. Protective and risk factors associated with adolescent sexual and reproductive health in the English-speaking Caribbean: a literature review. J Adolesc Health. 2012;50(1):5–23.CrossRefPubMed
18.
go back to reference Ayres JR, Paiva V, Franca I Jr, Gravato N, Lacerda R, Della Negra M, et al. Vulnerability, human rights, and comprehensive health care needs of young people living with HIV/AIDS. Am J Public Health. 2006;96(6):1001–6.CrossRefPubMedPubMedCentral Ayres JR, Paiva V, Franca I Jr, Gravato N, Lacerda R, Della Negra M, et al. Vulnerability, human rights, and comprehensive health care needs of young people living with HIV/AIDS. Am J Public Health. 2006;96(6):1001–6.CrossRefPubMedPubMedCentral
19.
go back to reference Rao D, Kekwaletswe T, Hosek S, Martinez J, Rodriguez F. Stigma and social barriers to medication adherence with urban youth living with HIV. AIDS Care. 2007;19(1):28–33.CrossRefPubMed Rao D, Kekwaletswe T, Hosek S, Martinez J, Rodriguez F. Stigma and social barriers to medication adherence with urban youth living with HIV. AIDS Care. 2007;19(1):28–33.CrossRefPubMed
20.
go back to reference Funck-Brentano I, Dalban C, Veber F, Quartier P, Hefez S, Costagliola D, et al. Evaluation of a peer support group therapy for HIV-infected adolescents. AIDS. 2005;19(14):1501–8.CrossRefPubMed Funck-Brentano I, Dalban C, Veber F, Quartier P, Hefez S, Costagliola D, et al. Evaluation of a peer support group therapy for HIV-infected adolescents. AIDS. 2005;19(14):1501–8.CrossRefPubMed
21.
go back to reference Hodgson I, Ross J, Haamujompa C, Gitau-Mburu D. Living as an adolescent with HIV in Zambia—lived experiences, sexual health and reproductive needs. AIDS Care. 2012;24(10):1204–10.CrossRefPubMed Hodgson I, Ross J, Haamujompa C, Gitau-Mburu D. Living as an adolescent with HIV in Zambia—lived experiences, sexual health and reproductive needs. AIDS Care. 2012;24(10):1204–10.CrossRefPubMed
22.
go back to reference Bikaako-Kajura W, Luyirika E, Purcell DW, Downing J, Kaharuza F, Mermin J, et al. Disclosure of HIV status and adherence to daily drug regimens among HIV-infected children in Uganda. AIDS Behav. 2006;10(4 Suppl):S85–93.CrossRefPubMed Bikaako-Kajura W, Luyirika E, Purcell DW, Downing J, Kaharuza F, Mermin J, et al. Disclosure of HIV status and adherence to daily drug regimens among HIV-infected children in Uganda. AIDS Behav. 2006;10(4 Suppl):S85–93.CrossRefPubMed
23.
go back to reference DeMatteo D, Wells LM, Goldie RS, King SM. The'family'context of HIV: a need for comprehensive health and social policies. AIDS Care. 2002;14(2):261–78.CrossRefPubMed DeMatteo D, Wells LM, Goldie RS, King SM. The'family'context of HIV: a need for comprehensive health and social policies. AIDS Care. 2002;14(2):261–78.CrossRefPubMed
24.
go back to reference World Health Organization. Guideline on HIV disclosure counselling for children up to 12 years of age. Geneva: World Health Organization; 2011. World Health Organization. Guideline on HIV disclosure counselling for children up to 12 years of age. Geneva: World Health Organization; 2011.
25.
go back to reference Catalani C, Philbrick W, Fraser H, Mechael P, Israelski DM. mHealth for HIV treatment & prevention: a systematic review of the literature. Open AIDS J. 2013;7:17–41.CrossRefPubMedPubMedCentral Catalani C, Philbrick W, Fraser H, Mechael P, Israelski DM. mHealth for HIV treatment & prevention: a systematic review of the literature. Open AIDS J. 2013;7:17–41.CrossRefPubMedPubMedCentral
26.
go back to reference Lester RT, Ritvo P, Mills EJ, Kariri A, Karanja S, Chung MH, et al. Effects of a mobile phone short message service on antiretroviral treatment adherence in Kenya (WelTel Kenya1): a randomised trial. Lancet. 2010;376(9755):1838–45.CrossRefPubMed Lester RT, Ritvo P, Mills EJ, Kariri A, Karanja S, Chung MH, et al. Effects of a mobile phone short message service on antiretroviral treatment adherence in Kenya (WelTel Kenya1): a randomised trial. Lancet. 2010;376(9755):1838–45.CrossRefPubMed
27.
go back to reference Pop-Eleches C, Thirumurthy H, Habyarimana JP, Zivin JG, Goldstein MP, De Walque D, et al. Mobile phone technologies improve adherence to antiretroviral treatment in a resource-limited setting: a randomized controlled trial of text message reminders. AIDS. 2011;25(6):825.CrossRefPubMedPubMedCentral Pop-Eleches C, Thirumurthy H, Habyarimana JP, Zivin JG, Goldstein MP, De Walque D, et al. Mobile phone technologies improve adherence to antiretroviral treatment in a resource-limited setting: a randomized controlled trial of text message reminders. AIDS. 2011;25(6):825.CrossRefPubMedPubMedCentral
28.
go back to reference Aranda-Jan CB, Mohutsiwa-Dibe N, Loukanova S. Systematic review on what works, what does not work and why of implementation of mobile health (mHealth) projects in Africa. BMC Public Health. 2014;14(1):1.CrossRef Aranda-Jan CB, Mohutsiwa-Dibe N, Loukanova S. Systematic review on what works, what does not work and why of implementation of mobile health (mHealth) projects in Africa. BMC Public Health. 2014;14(1):1.CrossRef
29.
go back to reference Finocchario-Kessler S, Goggin K, Khamadi S, Gautney B, Dariotis JK, Bawcom C, et al. Improving early infant HIV diagnosis in Kenya: study protocol of a cluster-randomized efficacy trial of the HITSystem. Implement Sci. 2015;10(1):96.CrossRefPubMedPubMedCentral Finocchario-Kessler S, Goggin K, Khamadi S, Gautney B, Dariotis JK, Bawcom C, et al. Improving early infant HIV diagnosis in Kenya: study protocol of a cluster-randomized efficacy trial of the HITSystem. Implement Sci. 2015;10(1):96.CrossRefPubMedPubMedCentral
30.
go back to reference Nowell LS, Norris JM, White DE, Moules NJ. Thematic Analysis: Striving to meet the trustworthiness criteria. Int J Qual Methods. 2017;16:1–13.CrossRef Nowell LS, Norris JM, White DE, Moules NJ. Thematic Analysis: Striving to meet the trustworthiness criteria. Int J Qual Methods. 2017;16:1–13.CrossRef
Metadata
Title
Challenges to and opportunities for the adoption and routine use of early warning indicators to monitor pediatric HIV drug resistance in Kenya
Authors
Nanlesta A. Pilgrim
Jerry Okal
James Matheka
Irene Mukui
Samuel Kalibala
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Pediatrics / Issue 1/2018
Electronic ISSN: 1471-2431
DOI
https://doi.org/10.1186/s12887-018-1209-5

Other articles of this Issue 1/2018

BMC Pediatrics 1/2018 Go to the issue